FOXN2 and cancer: Our findings suggest that miR-188-5p exerts significant cancer-promoting effects in HOXC6-mediated cancer progression by inhibiting FOXN2 expression; thus, miR-188-5p might be a potential prognostic marker and therapeutic target for HOXC6-overexpressing cancers.